Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 1, 2010, Pages 1-9

  Chima, Ranjit S ^a   Hake, Paul W ^a   Piraino, Giovanna ^a   Mangeshkar, Prajakta ^a   O'Connor, Michael ^a   Zingarelli, Basilia ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Ciglitazone; Hemorrhagic shock; Lung injury; Peroxisome proliferator activated receptor ; Phospho Akt

Indexed keywords

CASPASE 3; CIGLITAZONE; DIMETHYL SULFOXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL PRESSURE; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; HEMORRHAGIC SHOCK; LUNG INJURY; MALE; NICK END LABELING; NONHUMAN; RAT; RESUSCITATION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77649227338     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Yasuhara S, Asai A, Sahani ND and Martyn JA. Mitochondria, endoplasmic reticulum, and alternative pathways of cell death in critical illness. Crit Care Med 2007; 35: S488-495.
2. Riedl SJ and Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5: 897-907.
3. Martin TR, Nakamura M and Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med 2003; 31: S184-188.
4. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657.
5. Williams DL, Ozment-Skelton T and Li C. Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 2006; 25: 432-439.
6. Durham RM, Moran JJ, Mazuski JE, Shapiro MJ, Baue AE and Flint LM. Multiple organ failure in trauma patients. J Trauma 2003; 55: 608-616.
7. Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC and Sauaia A. The role of the lung in postinjury multiple organ failure. Surgery 2005; 138: 749-757; discussion 757-748.
8. Perl M, Lomas-Neira J, Chung CS and Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med 2008; 14: 465-475.
9. Jernigan TW, Croce MA and Fabian TC. Apoptosis and necrosis in the development of acute lung injury after hemorrhagic shock. Am Surg 2004; 70: 1094-1098.
10. Guan J, Jin DD, Jin LJ and Lu Q. Apoptosis in organs of rats in early stage after polytrauma combined with shock. J Trauma 2002; 52: 104-111.
11. Chima RS, Hake PW, Piraino G, Mangeshkar P, Denenberg A and Zingarelli B. Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock. Crit Care Med 2008; 36: 2849-2857.
12. Chou FS, Wang PS, Kulp S and Pinzone JJ. Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. Mol Cancer Res 2007; 5: 523-530.
13. Fajas L, Egler V, Reiter R, Miard S, Lefebvre AM and Auwerx J. PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner. Oncogene 2003; 22: 4186-4193.
14. Zingarelli B, Hake PW, Mangeshkar P, O'Connor M, Burroughs TJ, Piraino G, Denenberg A and Wong HR. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14- prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. Shock 2007; 28: 554-563.
15. Zingarelli B, Ischiropoulos H, Salzman AL and Szabo C. Amelioration by mercaptoethylguanidine of the vascular and energetic failure in haemorrhagic shock in the anesthetised rat. Eur J Pharmacol 1997; 338: 55-65.
16. Gavrieli Y, Sherman Y and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
17. Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A and Cook JA. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)- prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 2003; 171: 6827-6837.
18. Zhu P, Lu L, Xu Y and Schwartz GG. Troglitazone improves recovery of left ventricular function after regional ischemia in pigs. Circulation 2000; 101: 1165-1171.
19. Ware LB and Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
20. Alam HB, Austin B, Koustova E and Rhee P. Resuscitation-induced pulmonary apoptosis and intracellular adhesion molecule-1 expression in rats are attenuated by the use of Ketone Ringer's solution. J Am Coll Surg 2001; 193: 255-263.
21. Barlos D, Deitch EA, Watkins AC, Caputo FJ, Lu Q, Abungu B, Colorado I, Xu DZ and Feinman R. Trauma hemorrhagic shock-induced pulmonary epithelial and endothelial cell injury utilizes different programmed cell death signaling pathways. Am J Physiol Lung Cell Mol Physiol 2008;
22. Ayuste EC, Chen H, Koustova E, Rhee P, Ahuja N, Chen Z, Valeri CR, Spaniolas K, Mehrani T and Alam HB. Hepatic and pulmonary apoptosis after hemorrhagic shock in swine can be reduced through modifications of conventional Ringer's solution. J Trauma 2006; 60: 52-63.
23. Perl M, Chung CS, Lomas-Neira J, Rachel TM, Biffl WL, Cioffi WG and Ayala A. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 2005; 167: 1545-1559.
24. Khwaja A. Akt is more than just a Bad kinase. Nature 1999; 401: 33-34.
25. Amaravadi R and Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 2005; 115: 2618-2624.
26. Wu JS, Lin TN and Wu KK. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. J Cell Physiol 2009;
27. Lin CY, Gurlo T, Haataja L, Hsueh WA and Butler PC. Activation of peroxisome proliferatoractivated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 2005; 90: 6678-6686.
28. Fuenzalida K, Quintanilla R, Ramos P, Piderit D, Fuentealba RA, Martinez G, Inestrosa NC and Bronfman M. Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 antiapoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 2007; 282: 37006-37015.
29. Wu JS, Cheung WM, Tsai YS, Chen YT, Fong WH, Tsai HD, Chen YC, Liou JY, Shyue SK, Chen JJ, Chen YE, Maeda N, Wu KK and Lin TN. Ligand-Activated Peroxisome Proliferator-Activated Receptor-{gamma} Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3{varepsilon} Upregulation. Circulation 2009;
30. Liu HR, Tao L, Gao E, Qu Y, Lau WB, Lopez BL, Christopher TA, Koch W, Yue TL and Ma XL. Rosiglitazone inhibits hypercholesterolaemiainduced myeloperoxidase upregulation - a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc Res 2009; 81: 344-352.
31. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M and Martin TR. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163: 2217-2225.
32. Matute-Bello G, Liles WC, Frevert CW, Nakamura M, Ballman K, Vathanaprida C, Kiener PA and Martin TR. Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2001; 281: L328-335.
33. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, Zimmerman GA, Matthay MA and Ware LB. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 2002; 161: 1783-1796.
34. Perl M, Chung CS, Perl U, Lomas-Neira J, de Paepe M, Cioffi WG and Ayala A. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med 2007; 176: 591-601.